Renaissance Technologies’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-207,128
| Closed | -$3.95M | – | 3215 |
|
|
2026
Q1 | $3.95M | Sell |
207,128
-17,572
| -8% | -$388K | 0.01% | 1505 |
|
|
2025
Q4 | $5.43M | Buy |
224,700
+32,500
| +17% | +$850K | 0.01% | 1253 |
|
|
2025
Q3 | $4.9M | Sell |
192,200
-113,900
| -37% | -$2.7M | 0.01% | 1509 |
|
|
2025
Q2 | $6.59M | Buy |
306,100
+259,100
| +551% | +$5.84M | 0.01% | 1338 |
|
|
2025
Q1 | $1.07M | Buy |
47,000
+25,900
| +123% | +$682K | ﹤0.01% | 2382 |
|
|
2024
Q4 | $548K | Sell |
21,100
-33,280
| -61% | -$828K | ﹤0.01% | 2799 |
|
|
2024
Q3 | $1.36M | Buy |
54,380
+25,680
| +89% | +$607K | ﹤0.01% | 2259 |
|
|
2024
Q2 | $615K | Buy |
+28,700
| New | +$557K | ﹤0.01% | 2598 |
|
|
2023
Q2 | – | Sell |
-34,300
| Closed | -$746K | – | 3920 |
|
|
2023
Q1 | $746K | Buy |
+34,300
| New | +$771K | ﹤0.01% | 2658 |
|
|
2022
Q3 | – | Sell |
-179,200
| Closed | -$2.48M | – | 4034 |
|
|
2022
Q2 | $2.48M | Buy |
179,200
+151,600
| +549% | +$2.22M | ﹤0.01% | 2035 |
|
|
2022
Q1 | $627K | Buy |
+27,600
| New | +$727K | ﹤0.01% | 3035 |
|
|
2021
Q4 | – | Sell |
-66,600
| Closed | -$2.82M | – | 3902 |
|
|
2021
Q3 | $2.82M | Buy |
+66,600
| New | +$3.21M | ﹤0.01% | 1838 |
|
|
2021
Q2 | – | Sell |
-82,400
| Closed | -$2.97M | – | 3462 |
|
|
2021
Q1 | $2.97M | Buy |
+82,400
| New | +$3.26M | ﹤0.01% | 1974 |
|
|
2020
Q2 | – | Sell |
-39,200
| Closed | -$372K | – | 3443 |
|
|
2020
Q1 | $372K | Buy |
39,200
+8,946
| +30% | +$123K | ﹤0.01% | 2893 |
|
|
2019
Q4 | $490K | Buy |
30,254
+14,954
| +98% | +$243K | ﹤0.01% | 2911 |
|
|
2019
Q3 | $254K | Sell |
15,300
-105,300
| -87% | -$1.98M | ﹤0.01% | 3081 |
|
|
2019
Q2 | $2.04M | Sell |
120,600
-189,300
| -61% | -$3.3M | ﹤0.01% | 2316 |
|
|
2019
Q1 | $5.54M | Sell |
309,900
-133,600
| -30% | -$2.13M | 0.01% | 1741 |
|
|
2018
Q4 | $5.33M | Buy |
443,500
+15,600
| +4% | +$186K | 0.01% | 1686 |
|
|
2018
Q3 | $7.49M | Buy |
427,900
+221,000
| +107% | +$4.37M | 0.01% | 1543 |
|
|
2018
Q2 | $2.36M | Buy |
206,900
+179,100
| +644% | +$1.63M | ﹤0.01% | 2181 |
|
|
2018
Q1 | $143K | Sell |
27,800
-9,799
| -26% | -$53K | ﹤0.01% | 3226 |
|
|
2017
Q4 | $226K | Sell |
37,599
-49,301
| -57% | -$284K | ﹤0.01% | 3099 |
|
|
2017
Q3 | $496K | Buy |
+86,900
| New | +$360K | ﹤0.01% | 2787 |
|
Other funds holding BLFS
CC
FAM
Renaissance Technologies's BLFS Position: Q2 2026 in Review
Renaissance Technologies sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 207,128 shares — an estimated $3.95M sold.
Renaissance Technologies first reported a position in BLFS in Q3 2017 and held it in 24 quarters. The position peaked at $7.49M in Q3 2018. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.
- Renaissance Technologies reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 207,128 BioLife Solutions shares in Q2 2026, an estimated $3.95M.
- Renaissance Technologies first reported a position in BioLife Solutions in Q3 2017 and held it in 24 quarters.
- Renaissance Technologies's BioLife Solutions position peaked at $7.49M in Q3 2018.
- 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.